Kensington Pharma / Marketing Authorisation License Granted for Eptifibatide
Marketing Authorisation License Granted for Eptifibatide
10th August 2019
We are excited to announce that we have been granted marketing authorisation for our Eptifibatide range. We recently launched our Eptifibatide range at the Clinical Pharmacy Congress in London earlier this year.